Wijermans, P. 2009. Low dose Azanucleosides for high risk (s)MDS and AML. Hematology Meeting Reports (formerly Haematologica Reports). 2, 15 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v2i15.613.